Рынок лечения дегенеративных заболеваний дисков вырастет на 19% к 2036 году благодаря клеточной терапии

Degenerative Disc Disease Market to Surge at ~19% CAGR with Advancing Regenerative Cell Therapy Pipeline by 2036 - DelveInsight 09-07-2026 09:44 AM CET | Health & Medicine Press release from: DelveInsight Business Research LLP The Degenerative Disc Disease Treatment Market Size was found to be ~USD 1,200 million in the leading markets (the United States, the EU4, the United Kingdom, and Japan) in 2025, and is projected to reach ~USD 7,200 million by 2036, growing at a CAGR of ~19.04% from 2026 to 2036. DelveInsight's "Degenerative Disc Disease Market Insights, Epidemiology and Market Forecast - 2036" report delivers an in-depth understanding of Degenerative Disc Disease, historical and forecasted epidemiology, as well as the Degenerative Disc Disease market trends in the United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan. To Know in detail about the Degenerative Disc Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Degenerative Disc Disease Market Forecast: https://www.delveinsight.com/sample-request/degenerative-disc-disease-ddd-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr Some of the Key Facts of the Degenerative Disc Disease Market Report: * In April 2026, Mesoblast announced that, following topline Phase III results and a planned BLA submission, rexlemestrocel-L for CLBP associated with Degenerative Disc Disease may potentially receive FDA approval in Q2 CY2028 under a Priority Review pathway. * In April 2026, BioRestorative Therapies announced a strategic partnership with dermatology leader Dr. David J. Goldberg to lead clinical evaluation of its Regenerative BioCosmeceutical Platform, and separately announced a collaboration with 203 Creates to build and commercialize the platform. * In March 2026, DiscGenics's CEO highlighted the launch of the FDA-approved Phase III Program for IDCT (rebonuputemcel) at the CG 2026 Musculoskeletal Conference. * In January 2026, DiscGenics announced that the first patient was treated in its Phase III clinical trial evaluating IDCT (rebonuputemcel) in subjects with single-level, symptomatic mild-to-moderate lumbar Degenerative Disc Disease, with site activation underway across the United States. * The United States captured the largest Degenerative Disc Disease Treatment Market Size, at approximately USD 900 million in 2025. * Although Rebonuputemcel is considered the most promising emerging therapy in the 7MM Degenerative Disc Disease landscape, Rexlemestrocel-L and BRTX-100 also demonstrate strong potential, while earlier-stage assets including CELZ-201-DDT, AMG0103, and SB-01 remain in relatively nascent development stages. * IDCT (Rebonuputemcel) has received RMAT designation from the US FDA for its potential to address significant unmet needs in Degenerative Disc Disease. * In the US, there were approximately 14 million diagnosed prevalent cases of Degenerative Disc Disease in 2025, with the total 7MM diagnosed prevalent case count nearing 28 million cases. * Among the EU4, France accounted for the highest number of diagnosed prevalent cases of Degenerative Disc Disease, followed by Germany, while Spain accounted for the lowest number of cases in 2025. * Recent developments, including CMS granting New Technology Add-on Payment (NTAP) status for Carlsmed's aprevo implants and a new Category 1 CPT code for annular closure in 2026, are expected to support physician adoption and reimbursement uptake. * Key Degenerative Disc Disease Companies: Spine Biopharma, DiscGenics, Mesoblast, Grünenthal, AnGes, BioRestorative Therapies, and others. * Key Degenerative Disc Disease Therapies: SB-01, IDCT (Rebonuputemcel), Rexlemestrocel-L (MPC-06-ID), AMG0103 (NF-κB decoy oligonucleotide), BRTX-100, and others. Degenerative Disc Disease Overview and Diagnosis Degenerative Disc Disease is a progressive spinal condition characterized by the gradual breakdown of intervertebral discs, which act as cushions between the vertebrae, commonly occurring due to age-related wear and tear that leads to loss of disc hydration, elasticity, and structural integrity. As the discs deteriorate, patients may experience chronic neck or lower back pain, stiffness, reduced flexibility, and pain radiating to the arms or legs due to nerve compression, and in advanced stages the condition can contribute to disc herniation, spinal instability, or osteoarthritis of the spine. It is primarily caused by aging, repetitive mechanical stress, obesity, spinal injuries, poor posture, and genetic predisposition. Diagnosis relies on clinical evaluation and imaging tests, with physical examination assessing pain, mobility, and neurological function, while X-rays, MRI, or CT scans help identify disc degeneration, nerve compression, and spinal abnormalities; nerve conduction studies or EMG may also be performed in some cases. Get a Free sample for the Degenerative Disc Disease Market Forecast, Size & Share Analysis Report: https://www.delveinsight.com/sample-request/degenerative-disc-disease-ddd-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr Degenerative Disc Disease Epidemiology The Degenerative Disc Disease epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2022 to 2036, helping recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. Degenerative Disc Disease Epidemiology Segmentation: * Diagnosed Prevalence Cases of CLBP * Diagnosed Prevalence Cases of Specific CLBP * Diagnosed Prevalence Cases of Degenerative Disc Disease * Severity-specific Cases of Degenerative Disc Disease * Age-specific Cases of Degenerative Disc Disease * Type-specific Cases of Degenerative Disc Disease * Total Treated Cases of Degenerative Disc Disease Key epidemiological findings include: In 2025, Degenerative Disc Disease predominantly affected females in the United States, with 7,951,082 cases compared to 6,282,074 cases in males; by 2036, these figures are expected to rise to 8,933,829 cases in females and 7,058,533 cases in males. In the US, approximately 30.8% of prevalent cases in 2025 occurred in individuals below 60 years, while around 69.2% were reported in the population aged 60 years and above. Download the report to understand which factors are driving Degenerative Disc Disease epidemiology trends: Degenerative Disc Disease Epidemiology Forecast: https://www.delveinsight.com/sample-request/degenerative-disc-disease-ddd-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr Degenerative Disc Disease Treatment The primary goals of Degenerative Disc Disease treatment are to relieve pain, improve mobility, reduce inflammation, and enhance quality of life. Current management includes physical therapy, lifestyle modification, NSAIDs, muscle relaxants, corticosteroid injections, and surgical procedures such as spinal fusion or artificial disc replacement in severe cases. For most patients, the condition can be successfully treated with conservative, non-surgical care consisting of anti-inflammatory and pain medication combined with physical therapy and exercise; surgery is generally considered only after 6 months of unsuccessful non-surgical care or when everyday activities are significantly constrained. Lumbar fusion (ALIF, LLIF/XLIF, TLIF, and PLIF) remains the most widely performed surgical intervention, though data show only modest superiority over intensive conservative care at 4-year follow-up, raising cost-effectiveness concerns at ~USD 60,000-100,000 per procedure, with reoperation rates reaching 15-20% within 5 years and "failed back surgery syndrome" affecting an estimated 10-40% of patients. Degenerative Disc Disease Unmet Needs * Delayed diagnosis and difficulty identifying the exact pain source * Significant impact on quality of life (QoL) and daily functioning * Chronic pain and mobility limitations in aging populations * Limitations of existing pain management therapies, and others Degenerative Disc Disease Drugs Uptake and Pipeline Development Activities The drug chapter provides a detailed, market-focused review of the emerging Degenerative Disc Disease pipeline across Phase I-III clinical trials, covering mechanism of action, clinical trial data, regulatory approvals, patents, collaborations, and strategic partnerships for each therapy. Emerging Pipeline Therapies: * SB-01: Spine Biopharma - A first-in-class intradiscal injectable peptide therapy targeting Transforming Growth Factor Beta 1 (TGF-β1), which is linked to inflammation, disc degeneration, and discogenic pain; by modulating abnormal TGF-β1 signaling, SB-01 aims to reduce pain, improve function, and potentially slow disease progression as a non-surgical, non-opioid option. * IDCT (Rebonuputemcel): DiscGenics - An allogeneic injectable cell therapy using progenitor disc cells derived from adult human intervertebral disc tissue to promote disc regeneration, reduce chronic low back pain, and improve disc function, targeting the underlying degeneration process rather than symptoms alone; it has received RMAT designation from the FDA. * Rexlemestrocel-L (MPC-06-ID): Mesoblast and Grünenthal - A regenerative therapy using mesenchymal precursor cells, currently in Phase III for CLBP associated with Degenerative Disc Disease. * AMG0103 (NF-κB decoy oligonucleotide): AnGes - A synthetic oligonucleotide NF-kappa B inhibitor in Phase II for chronic discogenic lumbar back pain. * BRTX-100: BioRestorative Therapies - An autologous stem cell therapy in Phase II for chronic lumbar disc disease, using intradiscal cell replacement. Discover more about therapies set to grab major Degenerative Disc Disease market share: Degenerative Disc Disease Treatment Landscape: https://www.delveinsight.com/sample-request/degenerative-disc-disease-ddd-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr Degenerative Disc Disease Market Outlook The Degenerative Disc Disease Therapeutics Market is undergoing a significant transformation, moving beyond conventional pain management and surgical interventions toward regenerative and disease-modifying therapeutic approaches. The growing development of cell-based therapies, biologics, and gene-based technologies reflects a shift toward addressing the underlying mechanisms of disc degeneration, inflammation, and tissue damage. With continued advancement of pipeline candidates such as SB-01, IDCT (Rebonuputemcel), Rexlemestrocel-L (MPC-06-ID), AMG0103, and BRTX-100, the treatment landscape is evolving similarly to other chronic musculoskeletal disorders where regenerative medicine is driving broader therapeutic innovation. The United States is expected to remain the major Degenerative Disc Disease market due to the high prevalence of chronic low back pain, an aging population, sedentary lifestyle patterns, increasing adoption of minimally invasive procedures, and improved access to advanced spine care and diagnostic technologies. Key Factors Driving the Degenerative Disc Disease Market * Rising Degenerative Disc Disease Prevalence: The increasing prevalence of Degenerative Disc Disease, particularly among females, is a primary driver of market expansion, with ~14 million diagnosed prevalent cases in the US in 2025. * Rising Opportunities in Targeted Therapies: Advancing understanding of disc degeneration and inflammation is driving opportunities for targeted therapies focused on pain reduction, tissue regeneration, and slowing disease progression through regenerative and cell-based approaches. * Emerging Competitive Landscape: The therapeutics market landscape is evolving, with several regenerative and disease-modifying candidates - including SB-01, IDCT (Rebonuputemcel), Rexlemestrocel-L (MPC-06-ID), and AMG0103 - under active clinical development. Degenerative Disc Disease Market Barriers * Lack of a Validated Classification System: Degenerative Disc Disease lacks a universally accepted, validated classification system integrating imaging grade, clinical phenotype, biomechanical subtype, and psychosocial risk, contributing to heterogeneous trial outcomes and inconsistent treatment algorithms. * Poor Adherence to Conservative Management: Conservative management remains first-line, yet adherence rates are below 40% at 12 months, driving premature escalation to invasive interventions. * Opioid-Related Risks: Long-term opioid use in Degenerative Disc Disease carries addiction risk and evidence of opioid-induced hyperalgesia, counterproductively worsening pain chronicity. * High Surgical Costs and Reoperation Rates: Lumbar fusion procedures cost an estimated USD 60,000-100,000 per procedure and show only modest superiority over intensive conservative care, with reoperation rates of 15-20% within 5 years. * Underrepresentation of Sex-Specific Progression: Women experience accelerated post-menopausal disc degeneration linked to estrogen-dependent proteoglycan decline, yet sex-specific disease progression remains underrepresented in current treatment guidelines and trial stratification. Scope of the Degenerative Disc Disease Market Report * Study Period: 2022-2036 * Forecast Period: 2026-2036 * Coverage: 7MM * Key Degenerative Disc Disease Companies: Spine Biopharma, DiscGenics, Mesoblast, Grünenthal, AnGes, BioRestorative Therapies, and others * Key Degenerative Disc Disease Therapies: SB-01, IDCT (Rebonuputemcel), Rexlemestrocel-L (MPC-06-ID), AMG0103 (NF-κB decoy oligonucleotide), BRTX-100, and others * Degenerative Disc Disease Market Segmented by: Region/Geographies, Drugs/Therapies * Degenerative Disc Disease Therapeutic Assessment: Current marketed and emerging therapies * Degenerative Disc Disease Market Dynamics: Market drivers and market barriers * Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Conjoint Analysis, Market entry strategies * Degenerative Disc Disease Unmet Needs, KOL's views, Analyst's views, Market Access and Reimbursement Company Name: DelveInsight Business Research LLP Contact Person: Kanishk Kumar Email: [email protected] Phone: 9650213330 Address: 304 S. Jones Blvd #2432 City: Las Vegas State: NV Country: United States Website: https://www.delveinsight.com/ About Us DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve. This release was published on openPR. Permanent link to this press release: Copy Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release. You can edit or delete your press release Degenerative Disc Disease Market to Surge at ~19% CAGR with Advancing Regenerative Cell Therapy Pipeline by 2036 - DelveInsight here News-ID: 4623353 • Views: … 09-07-2026 | Health & Medicine DelveInsight Business Research LLP The Dry Eye Disease Treatment Market Size is poised for consistent growth, with … DelveInsight's Dry Eye Disease Treatment Market Insights Report 2032 provides the current and forecast market analysis, individual leading Dry Eye Disease Treatment Companies market shares, challenges, Dry Eye Disease Treatment Market Drivers, barriers, trends, and key market Dry Eye Disease Treatment companies in the market. To read more about the latest highlights related to the Dry Eye Disease Treatment Market, get a snapshot of the key highlights entailed in the Market … 09-07-2026 | Health & Medicine DelveInsight Business Research LLP The Digital Biopsy Market Size is poised for consistent growth, with a projected … DelveInsight's Digital Biopsy Market Insights Report 2032 provides the current and forecast market analysis, individual leading Digital Biopsy Companies market shares, challenges, Digital Biopsy Market Drivers, barriers, trends, and key market Digital Biopsy companies in the market. To read more about the latest highlights related to the Digital Biopsy Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/digital-biopsy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Digital Biopsy Market … 09-07-2026 | Health & Medicine DelveInsight Business Research LLP The Sinuscope Market Size is poised for consistent growth, with a projected CAGR … DelveInsight's Sinuscope Market Insights Report 2032 provides the current and forecast market analysis, individual leading Sinuscope Companies market shares, challenges, Sinuscope Market Drivers, barriers, trends, and key market Sinuscope companies in the market. To read more about the latest highlights related to the Sinuscope Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/sinuscope-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Sinuscope Market Report • The Sinuscope Market is estimated to … 09-07-2026 | Health & Medicine DelveInsight Business Research LLP The Skull Clamps Market Size is poised for consistent growth, with a projected C … DelveInsight's Skull Clamps Market Insights Report 2032 provides the current and forecast market analysis, individual leading Skull Clamps Companies market shares, challenges, Skull Clamps Market Drivers, barriers, trends, and key market Skull Clamps companies in the market. To read more about the latest highlights related to the Skull Clamps Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/skull-clamp-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Skull Clamps Market … All 5 Releases 07-03-2023 | IT, New Media & Software ReportsnReports Disc Manufacturing Market Size in 2023 To 2029 | Disc Makers, Atomic Disc, Bison … The research report includes a comprehensive evaluation of the market share, growth strategies, capabilities, and product offerings of key players in the Disc Manufacturing market. It aims to assist new entrants and stakeholders in understanding and analyzing upcoming challenges and opportunities. The report also highlights the major drivers, restraints, challenges, and opportunities in the Disc Manufacturing market. It provides a clear understanding of the factors that have shaped the overall … 03-28-2023 | Industry, Real Estate & Constr … DeepResearchReports Disc Manufacturing Market Revenue and Growth 2023, Upcoming Trends, Demand, Oppo … The Disc Manufacturing market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with development … 03-10-2023 | Business, Economy, Finances, B … Stratagem Market Insights New Trends of Disc Manufacturing Market increasing demand,Analysis by Industry G … Overview The Disc Manufacturing Market research study is a professional report with premium insights into the size of the business, current patterns, drivers, risks, potential outcomes, and major segments. The Industry Report forecasts the future growth of the market based on precise assumptions. Furthermore, based on input from industry experts, the report provides actionable insights into the Disc Manufacturing market's future growth to assist readers in developing effective strategies. The research … 03-06-2023 | Industry, Real Estate & Constr … The Market Insights Disc Golf Market: Latest Market Developments and Their Implications for Your Bu … Global Disc Golf Market Size was estimated at USD 175.2 million in 2021 and is projected to reach USD 538.6 million by 2028, exhibiting a CAGR of 17.4% during the forecast period. Market Overview: Global Disc Golf Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through … 02-14-2022 | Business, Economy, Finances, B … Infinity Business Insights Disc Golf Market 2022 | Emerging Technologies, COVID-19 Impact, Business Trends, … "Infinity Business Insights has released a new report which examines the Global Disc Golf Market Research Report in-depth, covering future trends, size, share, past, current data, as well as in-depth analysis and forecasts to 2022 - 2028. The report is based on studies of small and large components in the Disc Golf market which is reflected in its broad segmentation and geographic section. The growth potential of the Disc Golf … 04-27-2021 | Sports Rocket Discs Disc golf shop. disc golf store Rocket Discs is a definitive online Disc Golf Discs supplier organization in Denmark and every European country and this is truly outstanding "Disc Golf" looks for Golf Discs darlings. We have the greatest choice of Disc Sports items in Denmark off and on the web. With agreeable exhortation and learned staff, we mean to see the fledgling snared on any Disc Sport from their first Frisbee (toss), just as furnishing …